Skip to contentClarengateINTELLIGENCE
Companies/06704572

Tangent Reprofiling Limited

Other research and experimental development on natural sciences and engineering · London

ActiveUnited KingdomIncorporated 2008Private Limited Company
Register Ask analyst

Documents & history

Available account evidence and business events. This is not a complete filing history or document library.

Accounts to 2025-12-31

IXBRL · 49 source facts · 16 selected values

Validation findings
XBRL valid
Reporting period
2025-01-01 to 2025-12-31
Extraction status
complete
Numeric facts
18
Documents processed
1
XBRL standards validation
valid
Filing-profile validation
invalid
Parser
arelle 2.44.4
Taxonomy
FRS-102-2025-01-01.xsd
Currency
GBP
Source identifier
Prod224_2608_06704572_20251231
Source archive
Accounts_Monthly_Data-August2026.zip

Extraction findings: filing rules invalid. These describe source processing, not an audit opinion on the company.

Accounts to 2024-12-31

IXBRL · 107 source facts · 20 selected values

Validation findings
XBRL valid
Reporting period
2024-01-01 to 2024-12-31
Extraction status
complete
Numeric facts
48
Documents processed
1
XBRL standards validation
valid
Filing-profile validation
invalid
Parser
arelle 2.44.4
Taxonomy
FRS-102-2023-01-01.xsd
Currency
GBP
Source identifier
Prod224_2509_06704572_20241231
Source archive
Accounts_Monthly_Data-September2025.zip

Extraction findings: filing rules invalid. These describe source processing, not an audit opinion on the company.

Accounts to 2023-12-31

IXBRL · 112 source facts · 18 selected values

Not assessed
legacy record
Reporting period
2023-01-01 to 2023-12-31
Extraction status
Legacy / not assessed
Numeric facts
52
Documents processed
Not recorded
XBRL standards validation
Not assessed
Filing-profile validation
Not assessed
Parser
Legacy parser
Taxonomy
FRS-102-2022-01-01.xsd
Currency
GBP
Source identifier
Prod224_2366_06704572_20231231
Source archive
Accounts_Monthly_Data-July2024.zip

Accounts to 2022-12-31

IXBRL · 112 source facts · 18 selected values

Not assessed
legacy record
Reporting period
2022-01-01 to 2022-12-31
Extraction status
Legacy / not assessed
Numeric facts
52
Documents processed
Not recorded
XBRL standards validation
Not assessed
Filing-profile validation
Not assessed
Parser
Legacy parser
Taxonomy
FRS-102-2021-01-01.xsd
Currency
GBP
Source identifier
Prod224_0021_06704572_20221231
Source archive
Accounts_Monthly_Data-July2023.zip

Accounts to 2021-12-31

IXBRL · 117 source facts · 18 selected values

Not assessed
legacy record
Reporting period
2021-01-01 to 2021-12-31
Extraction status
Legacy / not assessed
Numeric facts
54
Documents processed
Not recorded
XBRL standards validation
Not assessed
Filing-profile validation
Not assessed
Parser
Legacy parser
Taxonomy
FRS-102-2021-01-01.xsd
Currency
GBP
Source identifier
Prod224_0107_06704572_20211231
Source archive
Accounts_Monthly_Data-June2022.zip

Accounts to 2020-12-31

IXBRL · 116 source facts · 18 selected values

Not assessed
legacy record
Reporting period
2020-01-01 to 2020-12-31
Extraction status
Legacy / not assessed
Numeric facts
54
Documents processed
Not recorded
XBRL standards validation
Not assessed
Filing-profile validation
Not assessed
Parser
Legacy parser
Taxonomy
FRS-102-2019-01-01.xsd
Currency
GBP
Source identifier
Prod224_0094_06704572_20201231
Source archive
Accounts_Monthly_Data-September2021.zip

Registered details

06704572
Status
Active
Type
Private Limited Company
Incorporated
2008-09-23
Jurisdiction
—
Registered office
4TH FLOOR, SILVERSTREAM HOUSE,, FITZROY STREET, LONDON, W1T 6EB, ENGLAND

Classification

1 SIC codes
72190

Capital & company events

Reconstructed equity rounds and matched research funding.

Equity fundraising

0 SH01-derived rounds

No reconstructed allotment rounds.

Research and innovation

1 matched grants
Tangent Reprofiling - Combination therapies for hormone-dependent cancers. Utilising an innovative therapeutic strategy of drugs and nutritional supplements. Treating Prostate (and Ovarian, Breast and Endometrial) cancers beyond castration resistance.Lead
Innovate UK · GRD Proof of Concept · 2012-01-01 – 2013-05-31
£100,000
awarded